Far-Infrared Therapy Treatment will be to Improve Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients

Far-Infrared Therapy Treatment will be to Improve Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients - Far-Infrared Therapy will be to Improve Unassisted Patency of AVF in HD Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011965

Enrollment

Registered

2013-10-13

Start date

2013-10-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients

Interventions

Far-Infrared Therapy for Patency of Arteriovenous Fistula

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hemodialysis patients who will be continued for over 12 months

Exclusion criteria

Exclusion criteria: skin disease patients blood clotting defect patients

Design outcomes

Primary

Measure	Time frame
secondary patency of AVF	—

Countries

Japan

Contacts

Public ContactHiroaki Io

Juntendo University Nephrology

hiroaki@juntendo.ac.jp03-5802-1065

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026